Lantern Pharma Says AI Cuts First-In-Human Drug Development Cost To $2 Million-$3 Million - Pulse 2.0

A pharmaceutical company claims AI has cut the cost of early-stage drug development dramatically, potentially making new medications faster and cheaper to bring to market. This could affect how quickly patients get access to life-saving treatments.